EP0341607A3
Anticoagulant peptide alcohols
Abstract
This invention relates to peptide derivatives of the formula X-A₁-A₂-A₃-A₄-A₅-A₆-A₇-A₈-A₉-A₁₀-ol<br /> which are useful anticoagulant agents.
Term
Term ended
Projected expiry passed 5 May 2009, 17.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| EP0158986B1 | Cites | European Patent Office (EPO) | A | Search report |
| EP0276014A2 | Cites | European Patent Office (EPO) | AP | Search report |
| CHEMICAL ABSTRACTS, vol. 111, 1989, page 18, abstract no. 70327w, Columbus, Ohio, US; J.L. KRSTENANSKY et al.: "C-terminal peptide alcohol, acid and amide analogs of desulfato hirudin54-55 as antithrombin agents." & THROMB. RES. 1989, 54(4), 319-25 | Non-patent | – | – | Search report |
32 members in 19 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 192409 | United States of America | – | |
| 19240988 | United States of America | A | |
| 19240988 | United States of America | A | |
| US19880192409 | – | – | – |
Members32
| Document | Office | Kind | |
|---|---|---|---|
| DK226889D0 | Denmark | D0 | |
| FI892222A0 | Finland | A0 | |
| NO891894D0 | Norway | D0 | |
| DK226889A | Denmark | A | |
| FI892222A | Finland | A | |
| NO891894L | Norway | L | |
| EP0341607A2 | European Patent Office (EPO) | A2 | |
| AU3451789A | Australia | A | |
| PT90504A | Portugal | A | |
| IL90220A0 | Israel | A0 | |
| IL90220D0 | Israel | D0 | |
| JPH01313500A | Japan | A | |
| ZA893346B | South Africa | B | |
| CN1041157A | China | A | |
| HUT51295A | Hungary | A | |
| US4971953A | United States of America | A | |
| KR900018138A | Republic of Korea | A | |
| EP0341607A3This record | European Patent Office (EPO) | A3 | |
| HU202556B | Hungary | B | |
| NZ228995A | New Zealand | A | |
| AU626070B2 | Australia | B2 | |
| PH26973A | Philippines | A | |
| EP0341607B1 | European Patent Office (EPO) | B1 | |
| AT108801T | Austria | T | |
| ATE108801T1 | Austria | T1 | |
| DE68916850D1 | Germany | D1 | |
| PT90504B | Portugal | B | |
| DE68916850T2 | Germany | T2 | |
| ES2060689T3 | Spain | T3 | |
| KR0131378B1 | Republic of Korea | B1 | |
| JP2916164B2 | Japan | B2 | |
| CA1341354C | Canada | C |
52 legal events, as 6 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Be: lapsedLapsedBERE | BERE | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Notification of lapseLapsedST | ST | FR | |
| Nl: lapsed or anulled due to non-payment of the annual feeLapsedNLV4 | NLV4 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Be: lapsedLapsedBERE | BERE | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Se: european patent in force in swedenEAL | EAL | EP | |
| Validation in greece3013711FG4A | FG4A | GR | |
| Definitive protectionFG2A | FG2A | ES | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Corresponds to:REF | REF | EP | |
| Fr: translation filedET | ET | EP | |
| Designated contracting statesAK | AK | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for examination filed17P | 17P | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0341607
- Publication, DOCDB
- 0341607
- Publication, EPODOC
- EP0341607
- Application
- 108159
- Application, DOCDB
- 89108159
- Application, EPODOC
- EP19890108159
Titles3
- German
- Antikoagulierende Peptid-Alkohole
- English
- Anticoagulant peptide alcohols
- French
- Peptides alcools anticoagulants
Classification
- CPC, 6
- C07K14/815
- C07K7/08
- A61K38/00
- A61P7/00
- A61P7/02
- A61K38/02
- IPC, 10
- A61K31 00
- A61K38 00
- A61K38 55
- A61P7 00
- A61P7 02
- C07K1 04
- C07K7 06
- C07K7 08
- C07K14 00
- C07K14 815
Designated states1
- Contracting states, 1
- Sweden